<DOC>
	<DOCNO>NCT00291421</DOCNO>
	<brief_summary>The purpose study collect compare information regard treatment outcome patient diagnose Alzheimer 's disease receiving either drug nondrug treatment . Information collect patient primary caregiver .</brief_summary>
	<brief_title>A Survey Study Treatment Outcome Management Patients Diagnosed With Alzheimer 's Disease</brief_title>
	<detailed_description>Dementia chronic , progressive brain disease may involve number symptom , include memory loss change personality , behavior , judgment , attention span , language thought . The common type dementia Alzheimer 's disease . Over time , patient Alzheimer 's disease may lose ability perform daily task relate personal care ( example bathing , dress , eat ) may unable handle money travel familiar place . Dementia one main reason people admit long-term care residential nursing homes.Treatments service prevent delay admission institution important may help decrease delay use health social care resource increase grow elderly population.This study large-scale survey provide information relate treatment Alzheimer 's disease , include information regard treatment pattern , characteristic patient Alzheimer 's disease , estimate cost care , disease outcome , patient ' ability function daily quality life caregiver . This study examine current management patient mild moderate Alzheimer 's disease real life setting . As opposed clinical trial particular group patient select participate treatment may specify possibly compare placebo ( inactive substance ) , study include wide variety patient treatment option closely represent management Alzheimer 's disease current clinical practice . Information collect patient Europe country treat doctor mild moderate Alzheimer 's disease . Patients receive treatment one follow medication approve treatment Alzheimer 's disease ( galantamine , donepezil , rivastigmine tacrine ) patient receive nondrug treatment ( disease progression monitoring , ginkgo extract , Vitamin E , estrogen , etc ) may participate . No treatment procedure specify medication provide Sponsor study . Treatment Alzheimer 's disease may stop , start change patient ' individual doctor appropriate . Information regard disease status , treatment , behavior , ability function use social care service ( day care , home care , meal wheel , social work ) collect patient . Information regard quality sleep patient caregiver , amount care require patient well-being/general quality life collect caregiver . Information collect every 6 month period 2 year , possible additional follow-up period 2 year . If patient study dy , collection information stop . If patient study permanently admit support care , nursing home residential care facility , collection information stop follow-up caregiver conduct end 2-year survey determine patient alive decease . The study hypothesis treatment Alzheimer 's disease medication may improve patient status , reduce caregiver dependency , improve caregiver quality life , reduce amount social care service need prolong prevent admission long-term institution patient Alzheimer 's disease Since study involve collection information , treatment require Sponsor medication supply Sponsor</detailed_description>
	<mesh_term>Alzheimer Disease</mesh_term>
	<mesh_term>Dementia</mesh_term>
	<mesh_term>Mental Disorders</mesh_term>
	<mesh_term>Psychotic Disorders</mesh_term>
	<mesh_term>Nervous System Diseases</mesh_term>
	<mesh_term>Brain Diseases</mesh_term>
	<criteria>Patients diagnose new previous mild moderate Alzheimer 's disease diagnose doctor accord medicallyaccepted definition Patients live ordinary household ( example home home family member friend , nurse home longterm care facility ) Patients currently participate another clinical trial</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2013</verification_date>
	<keyword>Alzheimer 's Disease</keyword>
	<keyword>Dementia</keyword>
	<keyword>Brain Disease</keyword>
	<keyword>Memory Loss</keyword>
	<keyword>Caregiver</keyword>
	<keyword>Primary Caregiver</keyword>
	<keyword>Observation</keyword>
	<keyword>galantamine</keyword>
	<keyword>donepezil</keyword>
	<keyword>rivastigmine</keyword>
	<keyword>Quality life</keyword>
</DOC>